JP2016504330A5 - - Google Patents

Download PDF

Info

Publication number
JP2016504330A5
JP2016504330A5 JP2015548841A JP2015548841A JP2016504330A5 JP 2016504330 A5 JP2016504330 A5 JP 2016504330A5 JP 2015548841 A JP2015548841 A JP 2015548841A JP 2015548841 A JP2015548841 A JP 2015548841A JP 2016504330 A5 JP2016504330 A5 JP 2016504330A5
Authority
JP
Japan
Prior art keywords
group
compound
range
pharmaceutically acceptable
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015548841A
Other languages
English (en)
Japanese (ja)
Other versions
JP6533466B2 (ja
JP2016504330A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/061090 external-priority patent/WO2014097178A1/en
Publication of JP2016504330A publication Critical patent/JP2016504330A/ja
Publication of JP2016504330A5 publication Critical patent/JP2016504330A5/ja
Application granted granted Critical
Publication of JP6533466B2 publication Critical patent/JP6533466B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015548841A 2012-12-18 2013-12-18 抗菌性化合物、その合成およびその適用 Expired - Fee Related JP6533466B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN5299/CHE/2012 2012-12-18
IN5299CH2012 2012-12-18
PCT/IB2013/061090 WO2014097178A1 (en) 2012-12-18 2013-12-18 Antimicrobial compounds, their synthesis and applications thereof

Publications (3)

Publication Number Publication Date
JP2016504330A JP2016504330A (ja) 2016-02-12
JP2016504330A5 true JP2016504330A5 (https=) 2017-01-26
JP6533466B2 JP6533466B2 (ja) 2019-06-19

Family

ID=54148251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015548841A Expired - Fee Related JP6533466B2 (ja) 2012-12-18 2013-12-18 抗菌性化合物、その合成およびその適用

Country Status (9)

Country Link
US (1) US9783490B2 (https=)
EP (1) EP2934563B1 (https=)
JP (1) JP6533466B2 (https=)
CN (1) CN104981249B (https=)
AU (1) AU2013365769B2 (https=)
BR (1) BR112015014391B1 (https=)
CA (1) CA2894202A1 (https=)
HK (1) HK1210437A1 (https=)
WO (1) WO2014097178A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105566149B (zh) * 2016-03-02 2017-05-24 郑州大学 具有抗菌活性的查尔酮阳离子抗菌肽模拟物及其制备方法
CN106995384B (zh) * 2017-04-21 2018-12-11 郑州大学 具有抗菌活性的二烷基阳离子两亲性抗菌肽模拟物及其制备方法
US20200354413A1 (en) 2017-12-15 2020-11-12 Dana-Farber Cancer Institute, Inc. Stabilized peptide-mediated targeted protein degradation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59309867D1 (de) 1992-09-03 1999-12-16 Boehringer Ingelheim Pharma Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
US5654451B1 (en) * 1993-01-14 2000-02-22 Magainin Pharma Amino acids and peptides having modified c-terminals and modified n-terminals
AU1441195A (en) * 1993-12-30 1995-07-17 Smithkline Beecham Corporation Phenylmethyl hexanamides, and the use thereof
US5663148A (en) 1994-07-12 1997-09-02 Abbott Laboratories Anaphylatoxin receptor ligands containing lipophilic residues
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
DE69612962T2 (de) * 1995-12-12 2001-11-15 Taiho Pharmaceutical Co. Ltd., Tokio/Tokyo Epoxysuccinamid-derivate oder deren salze und medikamente die diese enthalten
CA2217550A1 (en) * 1996-10-22 1998-04-22 F. Hoffmann-La Roche Ag Cationic lipids for gene therapy
BR9813554A (pt) * 1997-12-12 2001-07-24 Fuji Yakuhin Kogyo Kk Composto, uso do mesmo, processo para produzi-lo, composição farmacêutica ou veterinária, e, inibidor de metaloproteinase
WO2001040198A2 (fr) * 1999-11-30 2001-06-07 Aventis Pharma S.A. Derives macrocycliques de l'acide hydroxamique et leur utilisation en tant qu'antimicrobiens
JP2002161084A (ja) * 2000-11-28 2002-06-04 Sumitomo Pharmaceut Co Ltd 複素環誘導体
US7393836B2 (en) 2004-07-06 2008-07-01 Boehringer Ingelheim International Gmbh D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
GB0512751D0 (en) * 2005-06-22 2005-07-27 Glaxo Group Ltd New adjuvant
US8097582B2 (en) 2006-05-09 2012-01-17 Neobiotics Ab Peptide derivatives useful as antimicrobial agents and for treating wounds
AU2007304847A1 (en) * 2006-10-04 2008-04-10 Inimex Pharmaceuticals, Inc. Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
EP2091917A1 (en) * 2006-12-11 2009-08-26 Wyeth a Corporation of the State of Delaware Ion channel modulators
CN102757477B (zh) * 2011-04-27 2014-09-03 首都医科大学 烯丙基半胱氨酰氨基酸甲酯衍生物及其合成方法和应用
EP2709619B1 (en) * 2011-05-16 2017-10-11 Cellceutix Corporation Compounds for use in treatment of mucositis

Similar Documents

Publication Publication Date Title
CN110248926A (zh) Lsd1抑制剂及其制备方法和应用
JP2013541514A5 (https=)
UA106199C2 (ru) Производные аминобензамида как агенты, пригодные для использования для борьбы с паразитами животных
EA201001733A1 (ru) Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк)
RU2015143841A (ru) Ингибиторы hdac
NZ607580A (en) N-heteroaryl compounds
EP4606375A3 (en) Antibacterial compounds
TN2019000204A1 (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
CA3015494C (en) Novel compositions and therapeutic methods
MA53086B1 (fr) Thiophènecarboxamides substitués et analogues comme agents antibactériens
CU24667B1 (es) Derivados de aril-n-arilo para el tratamiento de una infección por virus de ácido ribonucleico (arn)
CN111770756A (zh) 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途
JP2016504330A5 (https=)
JP2014511366A5 (https=)
CN114364676A (zh) 新型三环芳香杂环化合物,及其制备方法、药物组合物和应用
CN114269751A (zh) 光学纯的氧杂螺环取代的吡咯并吡唑衍生物、其制法与医药上的用途
CN109689652A (zh) 稠杂环类衍生物、其制备方法及其在医学上的应用
CN115867545A8 (zh) 抗病毒素1,3-二氧代茚化合物
MA30540B1 (fr) Derives de quinolines et compositions pharmaceutiques de ces derives.
JP2012511558A5 (https=)
JP2011508779A5 (https=)
EA201100754A1 (ru) [4-(1-аминоэтил)циклогексил]метиламины в качестве антибактериальных средств
JP2014114278A (ja) 抗菌剤
RU2014131017A (ru) Хиназолиноновые производные в качестве ингибиторов hcv
CN116096718A (zh) 芳基酰胺化合物、包含其的药物组合物及其制备方法和用途